CAS 2688-77-9
:laudanosine
- (1S)-1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinoline
- (1S)-1-[(3,4-Dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methylisoquinoline
- (S)-(+)-Laudanosine
- 1-(3,4-Dimethoxybenzyl)-6,7-Dimethoxy-2-Methyl-1,2,3,4-Tetrahydroisoquinoline
- <span class="text-smallcaps">L</span>-(+)-Laudanosine
- DL-6,7-dimethoxy-1-((3,4-dimethoxyphenyl)methyl)-2-methylisoquinoline
- DL-laudanosine
- Isoquinoline, 1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-, (1S)-
- Isoquinoline, 1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-, (S)-
- NSC 35045
- O-Methylcodamine
- Laudanosine
- Einecs 220-253-2
- (1S)-1,2,3,4-Tetrahydro-1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methylisoquinoline
- Cisatracurium Besylate Impurity 49
- Voir plus de synonymes
(S)-Laudanosine
CAS :(S)-Laudanosine is the corresponding isomer of Laudanosine, which crosses the blood-brain barrier, with potential systemic toxicity and analgesic effects.Formule :C21H27NO4Degré de pureté :99.86%Couleur et forme :SolidMasse moléculaire :357.44(S)-Laudanosine
CAS :Produit contrôléApplications Laudanosine is a metabolite of the neuromuscular-blocking drugs Atracurium (A794500) and Cisatracurium (C496700) with potentially toxic systemic effects. It crosses the blood-brain barrier and may cause excitement and seizure activity.
References Canfell, P., et al.: Drug Metab. Dispos., 14, 703 (1986), Anselmi, E., et al.: J. Pharm. Pharmacol., 44, 337 (1992), Bohrer, H., et al.: Pharmacol. Toxicol., 73, 137 (1993),Formule :C21H27NO4Couleur et forme :NeatMasse moléculaire :357.44(S)-Laudanosine
CAS :Laudanosine is a gamma-aminobutyric acid (GABA) analog that is metabolized by the liver to form laudanosine. Laudanosine has been shown to be a competitive antagonist of benzodiazepine binding sites, including those of atracurium, mivacurium chloride, and diazepam. Laudanosine has also been shown to inhibit cyclic nucleotide phosphodiesterases in vitro, with clinical relevance for its use as an anti-epileptic drug.
Formule :C21H27NO4Degré de pureté :Min. 95%Masse moléculaire :357.44 g/mol





